Back to top

Kiniksa price target raised to $72 from $59 at Wedbush

Wedbush raised the firm’s price target on Kiniksa (KNSA) to $72 from $59 and keeps an Outperform rating on the shares. Arcalyst heads into Q2 earni...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Kiniksa Pharmaceuticals International, plc (KNSA)